Cargando…

Development and validation of a random forest model for predicting radiation pneumonitis in lung cancer patients receiving moderately hypofractionated radiotherapy: a retrospective cohort study

BACKGROUND: Radiation pneumonitis (RP) is a type of toxicity commonly associated with thoracic radiation therapy. We sought to establish a random forest (RF) model and evaluate its ability to predict RP in patients with non-small cell lung cancer (NSCLC) receiving moderately hypofractionated radioth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yang, Li, Zongjuan, Xiao, Han, Li, Zhenjiang, He, Jian, Du, Shisuo, Zeng, Zhaochong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816857/ https://www.ncbi.nlm.nih.gov/pubmed/36618794 http://dx.doi.org/10.21037/atm-22-3049

Ejemplares similares

Outcomes of Image-Guided Moderately Hypofractionated Radiotherapy for Stage III Non-Small-Cell Lung Cancer
por: Zhang, Yang, et al.
Publicado: (2021)

Higher serum sPD-L1 levels after radiotherapy indicate poor outcome in hepatocellular carcinoma patients
por: Zhang, Yang, et al.
Publicado: (2022)

Gut microbiota modulate radiotherapy-associated antitumor immune responses against hepatocellular carcinoma Via STING signaling
por: Li, Zongjuan, et al.
Publicado: (2022)

Induction Strategy for Locally Advanced Thymoma
por: Zhang, Yang, et al.
Publicado: (2021)

Shortened Radiation Time Promotes Recovery From Radiation-induced Lymphopenia in Early-Stage Non-small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy
por: Zhao, Qianqian, et al.
Publicado: (2022)

Emphysema quantification on computed tomography and its value in predicting radiation pneumonitis in lung cancer treated by stereotactic body radiotherapy
por: Ye, Luxi, et al.
Publicado: (2019)

Significance of low-dose radiation distribution in development of radiation pneumonitis after helical-tomotherapy-based hypofractionated radiotherapy for pulmonary metastases
por: Jo, In-Young, et al.
Publicado: (2014)

Genetic Variants in MTHFR Gene Predict ≥ 2 Radiation Pneumonitis in Esophageal Squamous Cell Carcinoma Patients Treated with Thoracic Radiotherapy
por: Zhang, Yang, et al.
Publicado: (2017)

Treatment-duration is related to changes in peripheral lymphocyte counts during definitive radiotherapy for unresectable stage III NSCLC
por: Zhao, Qianqian, et al.
Publicado: (2019)

Hypofractionated Radiotherapy Dose Scheme and Application of New Techniques Are Associated to a Lower Incidence of Radiation Pneumonitis in Breast Cancer Patients
por: Lee, Byung Min, et al.
Publicado: (2020)

A novel nomogram containing acute radiation esophagitis predicting radiation pneumonitis in thoracic cancer receiving radiotherapy
por: Tang, Wenjie, et al.
Publicado: (2021)

Additional adjuvant radiotherapy improves survival at 1 year after surgical treatment for pancreatic cancer patients with T(4), N(2) disease, positive resection margin, and receiving adjuvant chemotherapy
por: Wu, Lili, et al.
Publicado: (2023)

Radiation myelitis after hypofractionated radiotherapy with concomitant gefitinib
por: Lewitzki, Victor, et al.
Publicado: (2015)

Radiation Pneumonitis after Radiotherapy of Neck Lymphoma
por: Wei, Min, et al.
Publicado: (2014)

Comparison of long-term outcomes of stereotactic body radiotherapy (SBRT) via Helical tomotherapy for early-stage lung cancer with or without pathological proof
por: Fan, Shaonan, et al.
Publicado: (2023)

Ultrahypofractionated Radiotherapy versus Conventional to Moderate Hypofractionated Radiotherapy for Clinically Localized Prostate Cancer
por: Yamazaki, Hideya, et al.
Publicado: (2021)

Moderately Hypofractionated Radiotherapy with Simultaneous Integrated Boost in Prostate Cancer: A Comparative Study with Conventionally Fractionated Radiation
por: Cante, Domenico, et al.
Publicado: (2020)

Establishment and Verification of a Prediction Model for Symptomatic Radiation Pneumonitis in Patients with Esophageal Cancer Receiving Radiotherapy
por: Yang, Liu-Ting, et al.
Publicado: (2021)

Conversion and validation of rectal constraints for prostate carcinoma receiving hypofractionated carbon-ion radiotherapy with a local effect model
por: Wang, Weiwei, et al.
Publicado: (2021)

Hypofractionated radiotherapy for prostate cancer
por: Hegemann, Nina-Sophie, et al.
Publicado: (2014)

Integration of glucose and cardiolipin anabolism confers radiation resistance of HCC
por: Fang, Yuan, et al.
Publicado: (2021)

Promising Outcomes in Acromegaly Patients Receiving CyberKnife Stereotactic Hypofractionated Radiotherapy
por: Meral, Rasim, et al.
Publicado: (2023)

Moderate hypofractionated radiotherapy after prostatectomy for cancer patients: toxicity and clinical outcome
por: Barra, Salvina, et al.
Publicado: (2018)

A retrospective study of hypofractionated radiotherapy for keloids in 100 cases
por: Wen, Ping, et al.
Publicado: (2021)

Moderate hypofractionation for prostate cancer
por: Arcangeli, Stefano, et al.
Publicado: (2017)

Moderate hypofractionation for prostate cancer
por: Lee, W. Robert, et al.
Publicado: (2018)

Pre-radiotherapy FDG PET predicts radiation pneumonitis in lung cancer
por: Castillo, Richard, et al.
Publicado: (2014)

Factors Associated With Radiation Pneumonitis in Patients Receiving Electron Boost Radiation for Breast-Conserving Therapy: A Retrospective Review
por: Kawakami, Wataru, et al.
Publicado: (2020)

Moderately hypofractionated radiation therapy for breast cancer: A Brazilian cohort study
por: de Siqueira, Gabriela S.M., et al.
Publicado: (2022)

Toxicity and Outcomes of Moderately Hypofractionated Radiation for Prostate Cancer With Seminal Vesicle Involvement
por: Acklin-Wehnert, Scarlett, et al.
Publicado: (2023)

Pneumonitis in Patients Receiving Thoracic Radiotherapy and Osimertinib: A Multi-Institutional Study
por: Banla, Leou Ismael, et al.
Publicado: (2023)

Radiation recall pneumonitis induced by chemotherapy after thoracic radiotherapy for lung cancer
por: Ding, Xiao, et al.
Publicado: (2011)

High incidence of radiation pneumonitis in lung cancer patients with chronic silicosis treated with radiotherapy
por: Shen, Tianle, et al.
Publicado: (2019)

Automated prediction of dosimetric eligibility for hypofractionated prostate radiotherapy
por: Lausch, Anthony, et al.
Publicado: (2017)

The role of procalcitonin in differential diagnosis between acute radiation pneumonitis and bacterial pneumonia in lung cancer patients receiving thoracic radiotherapy
por: Wang, Zhiwu, et al.
Publicado: (2020)

Moderate hypofractionated radiotherapy is more effective and safe for localized prostate cancer patients: a meta-analysis
por: Cao, Ling, et al.
Publicado: (2016)

Retrospective study of hypofractionated stereotactic radiotherapy combined with whole brain radiotherapy for patients with brain metastases
por: Xie, Xue-Yi, et al.
Publicado: (2022)

Review of Hypofractionated Radiotherapy for Prostate Cancer
por: Spyropoulou, Despina, et al.
Publicado: (2012)

The Role of Hypofractionated Radiotherapy in Prostate Cancer
por: Benjamin, Linus C., et al.
Publicado: (2017)

Cost Minimization Analysis of Hypofractionated Radiotherapy
por: Yaremko, Hannah L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_csi4742rkg2mvvf9d5o3fbgftd